What is Ideaya Biosciences Inc?
, a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase, C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoadjuvant, and adjuvant settings. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 2.47B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 226,338 shares $985k | 0 |
| 3-6months | 19,550 shares $382k | 0 |
| 6-9months | 0 | 150,000 shares $1.6M |
| 9-12months | 0 | 0 |